Literature DB >> 18811240

Antibiotic-associated diarrhea: epidemiology, trends and treatment.

Lynne V McFarland1.   

Abstract

A common complication of antibiotic use is the development of gastrointestinal disease. This complication ranges from mild diarrhea to pseudomembranous colitis. Outbreaks of antibiotic-associated diarrhea (AAD) may also occur in healthcare settings, usually caused by Clostridium difficile. AAD typically occurs in 5-35% of patients taking antibiotics and varies depending upon the specific type of antibiotic, the health of the host and exposure to pathogens. The pathogenesis of AAD may be mediated through the disruption of the normal microbiota resulting in pathogen overgrowth or metabolic imbalances. The key to addressing AAD is prompt diagnosis followed by effective treatment and institution of control measures. Areas of active research include the search for other etiologies and more effective treatments.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18811240     DOI: 10.2217/17460913.3.5.563

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  72 in total

Review 1.  Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.

Authors:  Lynne V McFarland
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

Review 2.  Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis.

Authors:  Ronald F Lamont; Chia-Ling Nhan-Chang; Jack D Sobel; Kimberly Workowski; Agustin Conde-Agudelo; Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2011-04-02       Impact factor: 8.661

Review 3.  Chemical biology applied to the study of bacterial pathogens.

Authors:  Rebecca Anthouard; Victor J DiRita
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

Review 4.  Compositional dynamics of the human intestinal microbiota with aging: implications for health.

Authors:  B Lakshminarayanan; C Stanton; P W O'Toole; R P Ross
Journal:  J Nutr Health Aging       Date:  2014-11       Impact factor: 4.075

5.  PURLs: prescribing an antibiotic? Pair it with probiotics.

Authors:  Blake Rodgers; Kate Kirley; Anne Mounsey
Journal:  J Fam Pract       Date:  2013-03       Impact factor: 0.493

6.  The (p)ppGpp Synthetase RSH Mediates Stationary-Phase Onset and Antibiotic Stress Survival in Clostridioides difficile.

Authors:  Astha Pokhrel; Asia Poudel; Kory B Castro; Michael J Celestine; Adenrele Oludiran; Alden J Rinehold; Anthony M Resek; Mariam A Mhanna; Erin B Purcell
Journal:  J Bacteriol       Date:  2020-09-08       Impact factor: 3.490

Review 7.  Interactions Between the Gastrointestinal Microbiome and Clostridium difficile.

Authors:  Casey M Theriot; Vincent B Young
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

8.  Recurrent Clostridium difficile Infection in Children: Patient Risk Factors and Markers of Intestinal Inflammation.

Authors:  Maribeth R Nicholson; Jonathan D Crews; Jeffrey R Starke; Zhi-Dong Jiang; Herbert DuPont; Kathryn Edwards
Journal:  Pediatr Infect Dis J       Date:  2017-04       Impact factor: 2.129

9.  Enteral vancomycin and probiotic use for methicillin-resistant Staphylococcus aureus antibiotic-associated diarrhoea.

Authors:  Elizabeth Nicole Sizemore; Kenya Maria Rivas; Jose Valdes; Joshua Caballero
Journal:  BMJ Case Rep       Date:  2012-07-27

10.  Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection.

Authors:  Rana E El Feghaly; Jennifer L Stauber; Elena Deych; Carlos Gonzalez; Phillip I Tarr; David B Haslam
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.